SCI Pharmtech Inc Capital Reinvestment Ratio
SCI Pharmtech Inc capital reinvestment ratio. SCI Pharmtech Inc (4119) has a Capital Reinvestment Ratio of 0.39x as of June 2026, meaning it reinvests 0% of its operating cash flow (NT$156.75 Million) in capital expenditures (NT$60.99 Million). Check cash flow reinvestment rate of SCI Pharmtech Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of SCI Pharmtech Inc (2002–2025)
Capital reinvestment ratio of SCI Pharmtech Inc from 2002 to 2025. This chart tracks SCI Pharmtech Inc's Capital Reinvestment Ratio across 23 annual periods. Also explore SCI Pharmtech Inc equity growth rate to track the company's year-over-year net asset growth rate.
SCI Pharmtech Inc Capital Reinvestment Ratio by Year (2002–2025)
SCI Pharmtech Inc capital reinvestment ratio by year from 2002 to 2025. For the full cash flow conversion analysis, see SCI Pharmtech Inc (4119) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.77x | NT$220.32 Million | NT$610.00 Million | ▲ +151.7% |
| 2024 | 1.10x | NT$860.52 Million | NT$946.64 Million | ▼ -76.9% |
| 2023 | 4.77x | NT$215.77 Million | NT$1.03 Billion | ▲ +21.2% |
| 2022 | 3.94x | NT$296.56 Million | NT$1.17 Billion | ▲ +42.4% |
| 2021 | 2.77x | NT$280.28 Million | NT$774.98 Million | ▲ +1133.9% |
| 2020 | 0.22x | NT$971.53 Million | NT$217.70 Million | ▼ -13.3% |
| 2019 | 0.26x | NT$791.60 Million | NT$204.49 Million | ▼ -23.6% |
| 2018 | 0.34x | NT$480.18 Million | NT$162.44 Million | ▼ -35.4% |
| 2017 | 0.52x | NT$281.65 Million | NT$147.39 Million | ▲ +48.3% |
| 2016 | 0.35x | NT$502.11 Million | NT$177.20 Million | ▲ +7.6% |
| 2015 | 0.33x | NT$663.24 Million | NT$217.51 Million | ▼ -68.1% |
| 2014 | 1.03x | NT$358.77 Million | NT$369.15 Million | ▼ -68.2% |
| 2013 | 3.24x | NT$238.57 Million | NT$773.01 Million | ▲ +590.6% |
| 2012 | 0.47x | NT$385.57 Million | NT$180.90 Million | ▼ -20.7% |
| 2011 | 0.59x | NT$249.55 Million | NT$147.71 Million | ▼ -31.9% |
| 2010 | 0.87x | NT$218.96 Million | NT$190.34 Million | ▲ +52.1% |
| 2009 | 0.57x | NT$316.96 Million | NT$181.13 Million | ▲ +1.5% |
| 2008 | 0.56x | NT$245.29 Million | NT$138.12 Million | ▼ -43.6% |
| 2007 | 1.00x | NT$167.53 Million | NT$167.21 Million | ▼ -18.9% |
| 2006 | 1.23x | NT$131.62 Million | NT$162.00 Million | ▲ +165.3% |
| 2004 | 0.46x | NT$76.61 Million | NT$35.55 Million | ▼ -4.3% |
| 2003 | 0.48x | NT$206.86 Million | NT$100.29 Million | ▲ +24.4% |
| 2002 | 0.39x | NT$107.12 Million | NT$41.73 Million | — |